Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19

Saved in:
Bibliographic Details
Published in:Clinical microbiology and infection 2020-09, Vol.26 (9), p.1276-1277
Main Authors: Gevers, S., Kwa, M.S.G., Wijnans, E., van Nieuwkoop, C.
Format: Article
Language:English
Subjects:
Antiviral Agents - administration & dosage
Antiviral Agents - adverse effects
Antiviral Agents - pharmacokinetics
Betacoronavirus - drug effects
Chloroquine - administration & dosage
Chloroquine - adverse effects
Chloroquine - pharmacokinetics
Chloroquine - therapeutic use
Coronavirus Infections - drug therapy
COVID-19
Humans
Hydroxychloroquine - administration & dosage
Hydroxychloroquine - adverse effects
Hydroxychloroquine - pharmacokinetics
Hydroxychloroquine - therapeutic use
Letter to the Editor
Pandemics
Pneumonia, Viral - drug therapy
Randomized Controlled Trials as Topic
SARS-CoV-2
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1198-743X
1469-0691
DOI:10.1016/j.cmi.2020.05.006